Induced Pluripotency for the Study of Disease Mechanisms and Cell Therapy

作者: Toivo Maimets

DOI: 10.1007/978-94-017-9214-1_10

关键词: Disease mechanismsParacrine signallingDiseaseEmbryonic stem cellCell therapyBiologyGenetic enhancementPersonalized medicineInduced pluripotent stem cellNeuroscience

摘要: Pluripotent cells including induced pluripotent stem (iPS) are regarded as a powerful source for cell therapy, because these function both by direct replacement and also paracrine effects. Advantage of iPS is their unlimited availability. In this chapter we characterize the state starting from embryonic (ES) comparing them with cells. We describe different ways using cells: damaged in combination gene therapy. summarize recent achievements areas conclude that although developments highly promising, there still potential risks adverse effects, which need more fundamental research before therapy will become routine clinical practice. One promising area technology derivation patients genetic or other disorders use “human model human disease” to understand mechanisms disease possibly find new chemicals correct defective pathways. This approach has already led discoveries routes medical treatments potentially form efficient basis personalized patients.

参考文章(47)
David L Nelson, Richard A Gibbs, The Critical Region in Trisomy 21 Science. ,vol. 306, pp. 619- 621 ,(2004) , 10.1126/SCIENCE.1105226
S. Webb, M.H. Kaufman, Postimplantation development of tetraploid mouse embryos produced by electrofusion. Development. ,vol. 110, pp. 1121- 1132 ,(1990)
Kyle M. Loh, Bing Lim, A Precarious Balance: Pluripotency Factors as Lineage Specifiers Cell Stem Cell. ,vol. 8, pp. 363- 369 ,(2011) , 10.1016/J.STEM.2011.03.013
T Maimets, I Neganova, L Armstrong, M Lako, Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene. ,vol. 27, pp. 5277- 5287 ,(2008) , 10.1038/ONC.2008.166
Li B Li, Kai-Hsin Chang, Pei-Rong Wang, Roli K Hirata, Thalia Papayannopoulou, David W Russell, Trisomy Correction in Down Syndrome Induced Pluripotent Stem Cells Cell Stem Cell. ,vol. 11, pp. 615- 619 ,(2012) , 10.1016/J.STEM.2012.08.004
Ming Chen, Darrell J. Tomkins, Wojtek Auerbach, Colin McKerlie, Hagop Youssoufian, Lili Liu, Olga Gan, Madeleine Carreau, Anna Auerbach, Tim Groves, Cynthia J. Guidos, Melvin H. Freedman, Jay Cross, Dean H. Percy, John E. Dick, Alexandra L. Joyner, Manuel Buchwald, Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nature Genetics. ,vol. 12, pp. 448- 451 ,(1996) , 10.1038/NG0496-448
F. Soldner, R. Jaenisch, iPSC Disease Modeling Science. ,vol. 338, pp. 1155- 1156 ,(2012) , 10.1126/SCIENCE.1227682
Hans S Keirstead, Gabriel Nistor, Giovanna Bernal, Minodora Totoiu, Frank Cloutier, Kelly Sharp, Oswald Steward, Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. The Journal of Neuroscience. ,vol. 25, pp. 4694- 4705 ,(2005) , 10.1523/JNEUROSCI.0311-05.2005
Lisa E Olson, Joan T Richtsmeier, J Leszl, Roger H Reeves, A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes Science. ,vol. 306, pp. 687- 690 ,(2004) , 10.1126/SCIENCE.1098992